热点
关于我们
xx
xx
"
减重药
" 相关文章
辉瑞再次起诉诺和诺德,减重药群雄混战启幕
第一财经头条
2025-11-04T07:34:13.000000Z
丹麦巨头大裁员,掀开国产药千亿商机
虎嗅
2025-09-27T08:41:04.000000Z
翰宇药业:与三生蔓迪签署系列商业化协议,减重药物预计年销售峰值3000万支
界面快报
2025-08-19T23:54:38.000000Z
5300倍认购、超越“雪王”,减肥药概念股上市暴涨200%
36kr
2025-08-16T00:39:40.000000Z
歌礼制药:ASC47在临床前模型中显示与替尔泊肽联用的疗效胜过与司美格鲁肽联用
e公司-快讯
2025-08-13T00:21:10.000000Z
诺和诺德回应市场份额下滑:中国减重药销售仍在起量
深度
2025-08-06T15:58:07.000000Z
4300亿美元“灰飞烟灭”,全球“药王”,跌下神坛
钛媒体:引领未来商业与生活新知
2025-08-04T12:16:30.000000Z
4300亿美元“灰飞烟灭”,全球“药王”,跌下神坛
36kr
2025-08-04T06:13:47.000000Z
国产GLP-1减重药玛仕度肽于美团开启首发预约。7月3日,刚刚获批的减重创新药物玛仕度肽注射液在美团医药健康旗下美团自营大药房首发上线,加上此前全网独家首发...
虎嗅
2025-07-04T07:45:57.000000Z
Mounjaro在印度熱銷,禮來搶佔減肥藥藍海,領先諾和諾德一步
富途牛牛头条
2025-06-20T12:20:34.000000Z
减重药的这个生意能玩多久?
虎嗅
2025-05-26T09:34:17.000000Z
科学家发现流行减重药获益与风险共存
深度
2025-01-26T01:40:03.000000Z
减重药司美格鲁肽和替尔泊肽均在中国上市,马斯克亲身试验给出建议
第一财经杂志
2025-01-03T07:42:46.000000Z
抢购合规司美“减肥神药”的人,“怀念”起了代购
36kr
2024-12-13T06:45:38.000000Z
司美格鲁肽“平替”赛道,挤满中国企业
虎嗅
2024-12-09T01:37:23.000000Z
美股异动 | 诺和诺德盘前跌超3% 荷兰对报销其减肥药物费用持谨慎态度
格隆汇快讯
2024-07-17T09:19:15.000000Z
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
WSJ推特
2024-07-02T08:33:45.000000Z
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
WSJ推特
2024-06-30T11:03:48.000000Z
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
WSJ推特
2024-06-29T08:03:44.000000Z
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
WSJ推特
2024-06-25T06:33:42.000000Z